Knowledge Center

Article / Jan 01, 2004

Selecting lactose for a capsule-based dry powder inhaler

Authors:
  • Hartwig Steckel
  • Fadi Eskandar
  • Peter Villax
Source:
Pharmaceutical Technology Europe (2004), 16(4), 23

Dry powder inhalers are a well-accepted dosage form for pulmonary drug delivery and a wide variety are either currently available or development. This article examines a premetered, capsule-based multidose inhaler for which different qualities of _-lactose monohydrate were screened.

Also in the Knowledge Center

Related Content

Particle Engineering for Inhalation and Nasal

ËÄÉ«AV is a global expert and recognized leader in particle engineering, an essential technology when developing inhalation drug products.

Page
Read more

Membrane Technology

ËÄÉ«AV has a wide range of membrane capabilities at its disposal including nanofiltration and ultrafiltration.

Page
Read more

The ËÄÉ«AV Experience - New Jersey

Welcome to New jersey! From the boardwalk to the shore, bask in The ËÄÉ«AV Experience and let every moment in this bustling state bring you excitement and unforgettable memories.

Page
Read more